Both in Pharmaceuticals
Wave Life Sciences vs Zevra Therapeutics
Over the past year WVE returned −60.3% and ZVRA returned +1.0%; their daily moves had a correlation of 0.10.
WVE −60.3% ZVRA +1.0%Growth of $1, one year, split-adjusted
| Metric | WVE | ZVRA |
|---|---|---|
| Price | $3.59 | $10.28 |
| Market cap | $708.1M | $610.5M |
| Today | −1.10% | −0.77% |
| 1 month | −7.5% | +1.0% |
| 6 months | −51.0% | +2.1% |
| Year to date | −78.9% | +14.7% |
| 1 year | −56.5% | +1.6% |
| Revenue growth (YoY) | +72.9% | +53.3% |
| Gross margin | 100.0% | 96.2% |
| Net margin | −470.5% | 21.2% |
| P/E (TTM) | — | 10.5× |
| Price / sales | 10.0× | 4.5× |
| Net cash | $430.7M | $221.6M |
| Dividend yield | — | — |
| Volatility (60d) | 62.8% | 44.3% |
| Short % of float | 17.0% | 10.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).